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Abstract. In the context of a multicentre study on the 
use of technetium 99m hexakis-2-methoxyisobutylisoni- 
trile (99~nTc-Sestamibi), weevaluated the accuracy of the 
ventricular function assessed at rest by means of first- 
pass radionuclide angiocardiography acquired during 
the injection of the tracer for myocardial perfusion scin- 
tigraphy. The results were compared with first-pass tu- 
dies performed using reference tracers odium pertechne- 
tate Tc 99m or technetium 99m diethylene triamine pen- 
ta-acetic acid or with gated radionuclide angiocardiogra- 
phy. A total of 66 patients of the 105 enrolled in the 
study could be evaluated. The comparison of the first- 
pass studies was possible in 33 subjects with regard to 
the left ventricular ejection fraction, yielding r--0.909 
(P< 10-6), and in 22 cases with regard to the right ven- 
tricular ejection fraction, yielding r = 0.712 (P < 0.001). 
The comparison between the first-pass study using 
99mTc-Sestamibi and the equilibrium gated radionuclide 
angiocardiography was possible for the left ventricular 
ejection fraction in 26 cases, with r=0.937 (P<10-6), 
and for the right ventricular ejection fraction in 15 sub- 
jects, with r = 0.783 (P < 0.001). In conclusion, the assess- 
ment of ventricular function performed by acquiring a 
first-pass radionuclide angiocardiograph during the in- 
jection of 99mTc-Sestamibi for perfusion myocardial 
scintigraphy can be considered reliable and accurate, 
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when compared with the usually employed techniques. 
This result confirms the feasibility of a combined evalua- 
tion of perfusion and function at rest and during stress 
testing, which represents one of the most interesting ad- 
vantages offered by the use of 99mTc-Sestamibi. 
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In t roduct ion  
Perfusion studies using myocardial scintigraphy are 
among the most employed and probably the most accu- 
rate non-invasive tests for the diagnosis and assessment 
of coronary artery disease (Okada et al. 1980; Melin 
etal. 1981, 1985; Uhl etal. 1981; Leppo etal. 1982; 
Gerson 1987). On the other hand, the evaluation of left 
ventricular function by means of non-invasive methods, 
such as 2-dimensional echocardiography or radionuclide 
angiocardiography, has gained increasing importance in 
the past few years, owing to the high relevance of this 
variable in the management choices and in the prognos- 
tic stratification (Borer et al. 1980, 1987; Sanz et al. 
© Springer-Verlag t991 
179 
1982; Corbett et al. 1983; De Pace et al. 1983; Iskan- 
dr±an et al. 1985; Grodzinski et al. 1985; Multicenter 
Postinfarction Research Group 1986; Jones 1987). Up 
to now the two kinds of studies could not be performed 
simultaneously, since the characteristics of the perfusion 
tracer usually employed, thallium 201, are not suitable 
for the acquisition of a first-pass radionuclide angiocar- 
diography during its injection (Jansholt Anderson 1988). 
The availability of the isonitrile derivatives, a new class 
of myocardial perfusion tracers labelled with technetium 
99m (McKusick et al. 1986; Maddahi etal. 1987; Okada 
etal. 1988; Kiat et al. 1989), opens a newperspective, 
making possible the evaluation of function during perfu- 
sion studies (Schelbert 1987). The necessary prerequisite 
for this combined assessment is that the quality of radio- 
nuclide angiocardiography performed with the 99mTc- 
labelled isonitrile compound, injected at the required 
dosage for myocardial scintigraphy, has to be compara- 
ble with that obtained using a traditional radiopharma- 
ceutical such as sodium pertechnetate Tc 99m or techne- 
tium 99m diethylene triamine penta-acetic a id (99raTc- 
DTPA). 
In  this paper  we present  the results o f  left vent r icu lar  
funct ion  eva luat ion  wi th  f i rst-pass rad ionuc l ide  angio-  
card iography  per fo rmed in the context  o f  a mul t i cent re  
study concern ing  the use o f  technet ium 99m hexakis-2-  
methoxy isobuty l i son i t r i l e  (99mTc-Sestamibi)  in the eval-  
uat ion  o f  pat ients  wi th  coronary  artery disease. 
Methods 
The study involved nine centres in four different countries. In each 
country the use of 99mTc-Sestamibi (Cardiolite, Du Pont) was au- 
thorized according to local laws regarding the experimental evalua- 
tion of new radiopharmaceuticals, nd the study protocol was ap- 
proved by the local ethical committees. Informed consent was ob- 
tained from each patient. 
Patient population. The study protocol included the execution of 
first-pass radionuclide angiocardiography at rest with 99mTc-Sesta- 
mibi and of a comparative evaluation technique, possibly first-pass 
radionuclide angiocardiography employing another established 
tracer or, alternatively, either equilibrium gated radionuclide angio- 
cardiography or contrast ventriculography. Of the 105 patients 
recruited from 9 centres, 35 did not undergo any comparative as- 
sessment of ventricular function and were therefore xcluded from 
any further evaluation. Four more subjects were also excluded be- 
cause the interval between the 99mTc-Sestamibi study and the com- 
parative one exceeded 3 months. Therefore, a total of 66 patients 
(58 males and 8 females, mean age 55 _+ 9 years, range 37-74 years) 
could be evaluated with regard to the comparison of ventricular 
function. Coronary artery disease was diagnosed in 63 subjects, 
2 of whom also had valvular disease; one patient suffered from 
a dilated cardiomyopathy, one was considered normal, and finally 
the clinical data of one case were missing. Treatment for the under- 
lying disease was administered to 48 patients, including nitrates 
in 31, calcium channel blockers in 30 and /~-blocking agents in 
12. No changes in drug regimen were introduced uring the study, 
and the clinical condition of the patients remained stable. 
First-pass radionuclide angiography with 99~Tc-Sestamibi. Two dif- 
ferent types of 99mTe-Sestamibi k ts were employed, the first 
(RP30), which was administered to 9 patients, was frozen and 
needed to be stored at -20  ° C whereas the second (RP30A), which 
was used with the remaining 57 subjects, was lyophilized and could 
be stored at room temperature. After labelling with 99roTe both 
kits form the same complex without any demonstrable difference 
in chemistry or animal tests; the radiochemical purity assessed 
by chromatographic techniques was > 90% in all except one case 
(>95% in 81.8% of the reconstituted kits); therefore, the type 
of kit employed was not further considered in the evaluation of 
the results. 
The administered dose of 99Tc-Sestamibi ranged between 370 
and 1480 MBq (1~40 mCi) and the injected volume, between 0.35 
and 3 ml. None of the patients experienced any adverse effect; 
after injection some subjects perceived a transient metallic taste. 
The projection employed for the study was anterior in 10 pa- 
tients, left anterior oblique in 18 and right anterior oblique in 
38. Acquisition was performed in either list or frame mode using 
a small field-of-view gamma-camera (either muir±crystal or digital 
single crystal), equipped with a high sensitivity collimator and a 
20% window centred on the 140 keV photopeak of ~gmTc and 
interfaced with a computer. The study was elaborated according 
to the different software packages employed in the centres involved. 
At least three repeat determinations of the right and left ventricle 
ejection fraction were required and had to be recorded in the case 
report form. 
Comparative methods for ventricular function evaluation. According 
to the protocol the recommended comparative method was first- 
pass radionuclide angiocardiography with either sodium pertechne- 
rate Tc 99m or 99mTc-DTPA. This was actually performed with 
33 patients, in each case using the same projection and procedure 
employed when 99mTc-Sestamibi was administered; the time inter- 
val between the two studies was never shorter than 24 h, with 
a mean of 3.95_+3.47 days. The injected tracer activity was not 
significantly different from the 99mTc-Sestamibi dose. The left ven- 
trienlar ejection fraction was measured in all cases and the right 
ventricular ejection fraction, in 22. 
In 44 patients, equilibrium gated radionuclide angiocardiogra- 
phy could be used as a comparative method. In 32 of them, a 
comparison with the first-pass tudies was also possible, whereas 
in 12 the equilibrium study was the sole comparative radioisotopic 
method available. The time interval between the two studies was 
never shorter than 24 h, with a mean of 4.34±2.94 days. The equi- 
librium gated radionuclide angiocardiography was performed in 
each centre using a small field-of-view cardiological gamma-cam- 
era, equipped with a low-energy all-purpose collimator and a 20% 
window centred on the 140 keV photopeak of 99mTc and interfaced 
with a computer. The acquired data were processed according to 
the different routine procedures. In all patients the left ventricular 
ejection fraction was determined, while in 32 the right ventricular 
one was also measured. 
In 40 patients, left contrast ventriculography was performed 
as the comparative method, and it was the sole one available in 
20. The time interval between the 99mTe-Sestamibi first-pass angio- 
cardiography and the contrast ventriculography ranged from 1 to 
66 days (mean 18.4± 17.3 days). The left ventricular ejection frac- 
tion was calculated from the volumetric measurements of end-dia- 
stolic and end-systolic images, using either the monoplane or the 
biplane area-length method. 
Statistical analysis. The ejection fraction values obtained by the 
different methods were compared using the Student -test for paired 
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Fig. 1. Comparison of left ventricular ejection fraction (LVEF) 
measured using first-pass radionuclide angiocardiography per- 
formed with a reference tracer (FP) and with technetium 99m hexa- 
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Fig. 2. Comparison of left ventricular ejection fraction (LVEF) 
measured using gated equilibrium radionuclide angiocardiography 
(EGRA) and first-pass radionuclide angiocardiography with 99mTc- 
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Fig. 3. Comparison of left ventricular ejection fraction (LVEF) 
measured using contrast ventriculography and first-pass radionu- 
clide angiocardiography with 99mTc-Sestamibi: n = 33, r = 0.60 
data, linear regression and Pearson's correlation coefficient. The 
probability level was fixed at P<0,05. All data are expressed as 
the mean + SD. 
Results 
Left ventricular ejection fraction 
The left ventricular ejection fraction calculated with 
first-pass radionuclide angiocardiography using 99mTc- 
Sestamibi was not significantly different from the refer- 
ence first-pass tudy performed using either sodium per- 
technetate Tc 99m or 99mTc-DTPA: 49.1% _+12.7% 
(99mTc-Sestamibi) vs49.3% + 13.4%. A satisfactory cor- 
relation between the two values could be demonstrated" 
r=0.909 (P< 10-6), irrespective of the projection em- 
ployed, which was lways the same in each subject 
(Fig. 1). 
For the comparison of the results from equilibrium 
radionuclide angiocardiography and from contrast ven- 
triculography, only data from first-pass 99mTc-Sestamibi 
studies performed using right anterior oblique or anteri- 
or views (26 cases) were considered. The left ventricular 
ejection fraction calculated with the two methods was 
not significantly different: 51.8% _+ 13.5% (99mTc-Sesta- 
mibi) vs 50.2% 4-15.2%. The correlation with the equi- 
librium technique was very good with r=0.937 (P< 
10 -6) (Fig. 2). On the contrary, only a relatively low 
correlation with e results of contrast ventriculography 
could be achieved, with r=0.60 (P<0.001) (Fig. 3). 
However, also in this case no significant difference be- 
tween the value obtained by the two techniques could 
be found: 54.6% 4-11% (99mTc-Sestamibi) vs 58.3% 4- 
15.5%. 
Right ventricular ejection fraction 
Comparison of the right ventricular ejection fraction cal- 
culated with first-pass radionuclide angiocardiography 
using 99mTc-Sestamibi and a reference tracer showed an 
acceptable correlation: r = 0.712 (P< 0.001) (Fig. 4), and 
the two sets of values were not significantly different: 
42.6% _+ 7.7% (99mTc-Sestamibi) vs 41.7% _+ 7.2%. For 
comparison of the 99mTc-Sestamibi f rst-pass studies 
with the results of equilibrium angiocardiography, once 
again only the data obtained using right anterior oblique 
or anterior projection were considered (15 cases). The 
calculated values were not significantly different: 
45.5% + 7.6% (99mTc-Sestamibi) vs 44.4% _+ 5.9%, and 
showed a satisfactory correlation: r = 0.783 (P < 0.00a) 
(Fig. 5). 
Discussion 
Radionuclide angiocardiography, performed using ei- 
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Fig. 4. Comparison of right ventricular ejection fraction (RVEF) 
measured using first-pass radionuclide angiocardiography per- 
formed with a reference tracer (FP) and with 99mTc-Sestamibi: 
n=22, r=0.712 
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Fig. 5. Comparison of right ventricular ejection fraction (RVEF) 
measured using gated equilibrium radionuclide angiocardiography 
(EGRA) and first-pass radionuclide angiocardiography with 99mTc- 
Sestamibi : n = 15, r = 0.783 
an accurate and reproducible evaluation of both left and 
right ventricular function, by means of various quantita- 
tive parameters, chiefly the ejection fraction, and of the 
visualization of the ventricular wall motion pattern (Fol- 
land et al. 1977; Wackers et al. 1979; Jones et al. 1981). 
Several reports tress the value of a functional evaluation 
of the cardiac performance, in particular with prognostic 
stratification (Borer et al. 1980, 1987; Sanz et al. 1982; 
Corbett etal. 1983; De Pace etal. 1983; Grodzinski 
et al. 1985; Iskandrian et al. 1985; Multicenter Postin- 
farction Research Group 1986; Jones 1987). Since the 
strict relation between perfusion and function abnormal- 
ities has been demonstrated, the assessment of both of 
them would be highly desirable (Bodenheimer et al. 
1978; Massie etal. 1978; Rozanski etal. 1981) and 
would naturally be more accurate if simultaneously per- 
formed (Mena et al. 1984), as well as having the further 
advantage of reducing the radiation burden to the pa- 
tient. Using 2°tT1 as a perfusion tracer, functional as- 
sessment was possible only b performing a radionuclide 
angiocardiography during a separate study. The avail- 
ability of Sestamibi, an isonitrile derivative labelled with 
99mTc, which allows good quality perfusion imaging 
(McKusick etal. 1986; Maddahi etal. 1987; Okada 
et al. 1988; Kiat et al. 1989), opened the way to a com- 
bined assessment of perfusion and function by taking 
a first-pass radionuclide angiocardiography as the perfu- 
sion tracer is injected (Schelbert 1987). However, an 
evaluation of the study quality possible with 99mTc-Ses- 
tamibi was necessary, since the influence of lung and 
myocardial uptake on background activity has been ob- 
served (Baillet et al. 1989). A comparison of results ob- 
tained with 99mTc-Sestamibi with those using the estab- 
lished tracers, such as sodium pertechnetate Tc 99m or 
99mTc-DTPA, and with other accepted non-invasive ref- 
erence techniques, particularly equilibrium radionuclide 
angiocardiography, was therefore mandatory. This was 
the aim of the present study, planned as part of a more 
extensive and complete valuation of the reliability of 
99mTc-Sestamibi for perfusion myocardial scintigraphy. 
According to our results, the left ventricular ejection 
fraction values obtained with first-pass radionuclide an- 
giocardiography using 99mTc-Sestamibi were compara- 
ble with those from the established tracers, as reported 
by Baillet et al. (1989). This is true independent of the 
examination technique used. On the other hand, the 
comparison with equilibrium radionuclide angiocardio- 
graphy also yields good results, which are comparable 
with those obtained using the traditional tracers (Fol- 
land et al. 1977; Wackers et al. 1979; Kaul et al. 1984; 
Knesewitsch et al. 1986). For this comparison it is natu- 
rally necessary to take into account only the first-pass 
studies performed using a correct projection, such as 
right anterior oblique or anterior (Wackers 1987; De 
Puey 1988; Holman 1988), since the absolute value of 
a left ventricular ejection fraction calculated starting 
from a left anterior oblique projection is unreliable. The 
same is true when the first-pass ejection fraction has 
to be compared with another eference method such as 
contrast ventriculography. In this regard, our results 
were less satisfying when compared with already pub- 
lished data (Jengo etal. 1978; Iskandrian etal. 1981; 
Gal et al. 1986). This can be partly explained by the 
longer time interval which elapsed between the first-pass 
and this particular comparison method in our study 
group (Cohn et al. 1974; McAnulty et al. 1974), by the 
fact that the quantitative assessment of contrast ventri- 
culography was not performed according to a specific 
protocol but as part of the routine left heart catheteriza- 
tion procedure (Rogers et al. 1979) and by the presence 
in the study group of patients with poor left ventricular 
function (Iskandrian et al. 1982). The absence of any 
significant difference between the values calculated with 
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the two methods, however, allows one to exclude a sys- 
tematic error in the results of  99mTc-Sestamibi first-pass 
angiocardiography. 
Also, the right ventricular ejection fraction which 
was obtained using 99m-Sestamibi correlates with both 
the data attained using first-pass with other tracers and 
those of  equilibrium radionuclide angiocardiography. 
Again, only the 99mTc-Sestamibi first-pass studies per- 
formed in a correct projection were considered. The ana- 
tomical shape of  the right ventricle makes the ejection 
fraction calculation more difficult and justifies a lower 
level of  correlation among measures performed in differ- 
ent studies or with other methods (Maddahi et al. 1979; 
Manno et al. 1984). 
We may conclude that the evaluation of  cardiac func- 
tion with first-pass radionuclide angiocardiography per- 
formed during the injection of  99mTc-Sestamibi seems 
reliable and accurate. The execution of  combined studies 
of  perfusion and function coupled with an appropriate 
stress test is the logical consequence of  these preliminary 
experiences. This approach is certainly more demanding 
than a simple perfusion scintigraphy, for instance be- 
cause the gamma-camera is occupied during the entire 
exercise test. Moreover, the use of  a single-day protocol 
is no longer possible. Further studies are therefore neces- 
sary in order to identify in which patients the use of  
a combined evaluation is worthwhile. The simultaneous 
assessment of  perfusion and function, even if performed 
in selected cases only, appears to be a noteworthy advan- 
tage offered by 99mTc-Sestamibi over 2°iT1. 
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